Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You do realize that P3 trials are megabuck studies?
If total interest is now at 186 searches, then it is a number off that chart!! OFF THE CHARTS!! GO IPIX!!!
The powers that be want IPIX to remain under the radar. That will end with study end points met and positive phase 2 results. GO IPIX!!
Leo needs to get Brilacidin lined up with PUSH Health, user friendly and rapid results:
https://www.pushhealth.com/pages/faq?campaignid=757439920&adgroupid=40212795792&network=g&device=m&devicemodel=&gclid=CjwKCAjwmeiIBhA6EiwA-uaeFekAcnT9z1_IPqWfwCpN7BEYNB4IxHhdlC9UStqExtj9-_NPCLcGsxoCvMIQAvD_BwE
Ok if everything is going by industry and regulatory norms we’re in great shape! Thanks for the reply.
Is that the data lock??
Somebody’s really liking IPIX at 30 cents
Yes and the incredible thing about that article is that it was written OVER a year ago!!
That’s a lot of B. Do you think the oral rinse can play a role as well as an inhaler?
https://www.corerxpharma.com/contract-innovation-pharmaceuticals-formulate-sachets/
George Mason University
Would be awesome if Brilacidin could obviate this list of therapeutics with a nasal spray/inhaler by killing the virus at stage zero:
https://ippocrateorg.org/en/2020/12/15/how-to-treat-covid-19/
Seems like common sense to me…..
Interesting: “ Nasal Titers in Vaccinated are higher than Unvaccinated - ADE Antibody Dependent Enhancement”
https://153news.net/watch_video.php?v=8RYNHGOSSMW3
“ PCTL will release more information on the two new subsidiaries and the JV’s next week. The company will explain this massive O&G opportunity and their plan to effectively monetize fluid sales to the industry. ”
WHAT HAPPENED TO THIS??
“ It does not teach the immune system anything about the invader and does not provide lasting resistance/immunity. ”
But the patient is allowed to develop natural immunity in this process, all with a very high safety rating of 426.
Was there any talk of what the company is planning to do? Other than buyback shares?
We shall see
If this Doctors’ study is valid, there could be serious problems on the horizon for vaccinated folks:
https://rumble.com/vkb8pj-life-saving-long-term-cvd-vx-injury-mechanism-discovered-share-9m23sec.html
Schwab is showing 0.30 as the last trade, above the ask at the time of 0.298
Sweet close!! GO IPIX!!!
That article needs to be updated, look closely at he dates mentioned
Golden Cross coming up next
Yea “sold” to a manipulated ask
I would characterize that as material misinformation on the part of Schwab and TD. Here’s the thing, What can be done about it?
Is a 120 patient trial “big” enough?
PHIL=STHC? Buyer beware
Yea and how does the price go UP during RELENTLESS SELLING??
NICE!!!
That would be great if Brilacidin works prophylacticly, during full blown infection, AND post infection by inhibiting pulmonary fibrosis!! Given today’s data it should!
Keywords:
“Collectively, our data demonstrate that brilacidin exerts potent inhibition of SARS-CoV-2 against different strains of the virus in cell culture. ”
https://www.mdpi.com/1999-4915/13/2/271
I say we close way GREEN today!! GO IPIX!!!
IPIX TO THE MOON!!!!! ROCKET BLAST OFF!!!!
Yea that’s what I saw too
Brilacidin pronounced very similar to Penicillin.
The Brilacidin trial?
Copy that!!
Thanks farrelll90, I very much appreciate your extremely well informed contribution to this board and I read your posts with great interest.
From your research farrell90, would you say Brilacidin can help people with long term Covid 19?
Nice article, I just don’t get the part (and I’ve seen this many times before) where it appears the author writes all about a drug with qualities of Brilacidin and its potential therapeutic properties but somehow it never came up in all of their “research” to write the article. Seems impossible. Why is IPIX and Brilacidin so far under the radar? Serious question.